Compounds > cyclosporine

cyclosporine and Benign Monoclonal Gammopathies

cyclosporine has been researched along with Benign Monoclonal Gammopathies in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwabuchi, Y; Kataoka, H; Kojima, K; Makabe, S; Mochizuki, T; Moriyama, T; Nitta, K; Sato, K; Sato, M; Taneda, S; Tsuchiya, K1
Chiarolanza, I; Di Lernia, V; Ficarelli, E; Lallas, A; Possemato, N; Salvarani, C1
Abbal, M; Durand, D; Modesto, A; Rostaing, L1

Other Studies

3 other study(ies) available for cyclosporine and Benign Monoclonal Gammopathies

ArticleYear
Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    Nephrology (Carlton, Vic.), 2018, Volume: 23, Issue:8

    Topics: Adult; Biopsy; Cyclosporine; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney; Microscopy, Electron; Monoclonal Gammopathy of Undetermined Significance; Steroids; Treatment Outcome

2018
Frequency of monoclonal gammopathy in psoriatic patients receiving anti-TNF therapy compared with patients taking conventional drugs: a cross-sectional study.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:11

    Topics: Acitretin; Adalimumab; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Cyclosporine; Etanercept; Female; Humans; Immunosuppressive Agents; Infliximab; Keratolytic Agents; Male; Methotrexate; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Prevalence; Psoriasis; Tumor Necrosis Factor-alpha

2015
Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients.
    American journal of nephrology, 1994, Volume: 14, Issue:3

    Topics: Contraindications; Cyclosporine; Follow-Up Studies; Heart Transplantation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Immunosuppression Therapy; Kidney Transplantation; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Time Factors

1994